Suppr超能文献

临床巨细胞病毒分离株中UL97磷酸转移酶编码序列分析及赋予更昔洛韦耐药性的突变鉴定。

Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance.

作者信息

Chou S, Erice A, Jordan M C, Vercellotti G M, Michels K R, Talarico C L, Stanat S C, Biron K K

机构信息

Medical Service, VA Medical Center, Portland, OR 97201.

出版信息

J Infect Dis. 1995 Mar;171(3):576-83. doi: 10.1093/infdis/171.3.576.

Abstract

The UL97 phosphotransferase coding sequences of clinical cytomegalovirus (CMV) isolates, 10 resistant and 11 sensitive to ganciclovir, were compared to define mutations associated with drug resistance. In each ganciclovir-resistant isolate, a mutation was found that resulted in an amino acid substitution at codon 460 (4 isolates), codon 594 (2 isolates), or codon 595 (4 isolates). No sensitive isolate carried any of these mutations. Marker transfer studies showed that each mutation was capable of conferring ganciclovir resistance to the laboratory CMV strain AD169. Rapid diagnostic tests based on DNA amplification and restriction enzyme analysis were developed for these mutations. Specific mutant DNAs were detected when they constituted at least 10% of the population in the specimen. Several mutations in UL97 appear to be common markers for ganciclovir resistance, and their detection may be a rapid alternative to conventional cell culture susceptibility testing.

摘要

对10株对更昔洛韦耐药和11株对更昔洛韦敏感的临床巨细胞病毒(CMV)分离株的UL97磷酸转移酶编码序列进行比较,以确定与耐药相关的突变。在每株对更昔洛韦耐药的分离株中,均发现一个突变,该突变导致460密码子(4株分离株)、594密码子(2株分离株)或595密码子(4株分离株)发生氨基酸取代。没有敏感分离株携带这些突变中的任何一种。标记转移研究表明,每个突变都能够赋予实验室CMV毒株AD169对更昔洛韦的耐药性。针对这些突变开发了基于DNA扩增和限制酶分析的快速诊断试验。当标本中的特定突变DNA至少占群体的10%时,即可检测到。UL97中的几种突变似乎是更昔洛韦耐药的常见标志物,检测这些突变可能是传统细胞培养药敏试验的一种快速替代方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验